Alpna H. Seth
Alpna H. Seth is President, CEO, Secretary & Director at Nura Bio, Inc. and President, Chief Executive Officer & Director at Proneurotech, Inc. Dr. Seth is also on the board of Bio-Techne Corp., Seattle Genetics, Inc. and Women in Bio, Inc.
Alpna H. Seth previously held the position of Chief Operating Officer for Vir Biotechnology, Inc. and Senior VP & Global Head-Biosimilars Business at Biogen, Inc. and Managing Director at Biogen Idec Biotech India Pvt Ltd. (a subsidiary of Biogen, Inc.).
Dr. Seth received a doctorate from the University of Massachusetts Medical School.
|11/09/2020||3,665||Disposition at $306.95 per share.||1,124,972|
|11/09/2020||1,358||Disposition at $305.74 per share.||415,195|
|11/09/2020||3,125||Derivative/Non-derivative trans. at $125.05 per share.||390,781|
|11/09/2020||1,898||Derivative/Non-derivative trans. at $179.84 per share.||341,336|
|10/29/2020||391||Award at $0 per share.||0|
|10/24/2019||495||Award at $0 per share.||0|
|10/25/2018||514||Award at $0 per share.||0|
|10/26/2017||739||Award at $0 per share.||0|